Table 2 Global relative efficiency.
From: Assessment of global phase uncertainty in case-control studies
| Â | nr of individuals | per group (%) | Case-control study (%) | |||||
|---|---|---|---|---|---|---|---|---|
| Â | Total | ambiguous | % | min( |
|
|
|
|
hipROA | Â | Â | Â | Â | Â | Â | Â | Â |
control | 653 | 212 | 32.5 | 59.3 | 86.4 | 89.8 | 82.3 | 92.6 |
case | 61 | 22 | 36.1 | 77.9 | 81.4 | 78.5 | Â | Â |
Simulated data 1 | Â | Â | Â | Â | Â | Â | Â | Â |
control | 500 | 174 | 34.8 | 63.7 | 85.4 | 79.8 | 83.2 | 93.3 |
case | 500 | 181 | 36.2 | 53.9 | 88.6 | 77.3 | Â | Â |
)
- For each group min(
), 
and 
values were given, and for a the case-control study 
value was computed in terms of power of the global statistic T in (8). The subscript 2,3 indicates the relative efficiency of the haplotypes 112 and 121. 1Results from one simulated sample.